AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2025
Dec 24, 2025
35200_dirs_2025-12-23_e767b2a7-2230-43be-8f16-2294685c5361.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2025-12-22
Reporting Person: Rochlin Kate (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Common Stock | A | 7247 | $1.38 | Acquired | 9085 | Direct |
Footnotes
F1: Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.